85 related articles for article (PubMed ID: 1973574)
1. Idazoxan and CH-38083 affect gastric secretion by inhibiting alpha-2 adrenoceptors at vagal and sympathetic pathways.
Del Tacca M; Blandizzi C; Bernardini MC; Vizi SE
Acta Physiol Hung; 1990; 75 Suppl():81-2. PubMed ID: 1973574
[No Abstract] [Full Text] [Related]
2. Modulation of gastric acid secretion by peripheral presynaptic alpha 2-adrenoceptors at both sympathetic and parasympathetic pathways.
Blandizzi C; Bernardini MC; Vizi ES; Del Tacca M
J Auton Pharmacol; 1990 Oct; 10(5):305-12. PubMed ID: 1982112
[TBL] [Abstract][Full Text] [Related]
3. Failure of selective antagonists (CH-38083 and idazoxan) to distinguish between prejunctional and postjunctional alpha 2-adrenoreceptors.
Lonart G; Harsing LG; Folly G; Vizi ES
J Auton Pharmacol; 1989 Apr; 9(2):149-58. PubMed ID: 2565902
[TBL] [Abstract][Full Text] [Related]
4. Effect of CH-38083, a selective antagonist of alpha 2-adrenoceptors, on renal sympathetic function.
Dóda M; Vizi ES
Neuropharmacology; 1989 Feb; 28(2):135-40. PubMed ID: 2566132
[TBL] [Abstract][Full Text] [Related]
5. CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors.
Vizi ES; Harsing LG; Gaal J; Kapocsi J; Bernath S; Somogyi GT
J Pharmacol Exp Ther; 1986 Aug; 238(2):701-6. PubMed ID: 2874217
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the alpha-2-adrenoceptor labelling specificity of [3H]CH-38083.
Botos K; Gaál J; Fejér E
Acta Physiol Hung; 1990; 75 Suppl():41-2. PubMed ID: 1973572
[No Abstract] [Full Text] [Related]
7. The behavior of CH-38083 on putative alpha-2 adrenoreceptor subtypes.
Fejér E; Botos K; Körmöczy PS; Gaál J
Acta Physiol Hung; 1990; 75 Suppl():101-2. PubMed ID: 1973554
[No Abstract] [Full Text] [Related]
8. Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro.
Medgett IC; Langer SZ
J Pharmacol Exp Ther; 1984 Jun; 229(3):823-30. PubMed ID: 6144792
[TBL] [Abstract][Full Text] [Related]
9. The effect of yohimbine, WY 26392 and idazoxan on sympathetic nerve activity.
Ramage AG; Tomlinson A
Eur J Pharmacol; 1985 Feb; 109(2):153-60. PubMed ID: 2859996
[TBL] [Abstract][Full Text] [Related]
10. [Action of idazoxan on tachycardia following electric stimulation of the thoracic sympathetic chain in the rat].
Dabiré H; Fournier B; Schmitt H
C R Seances Soc Biol Fil; 1986; 180(2):170-3. PubMed ID: 2877721
[TBL] [Abstract][Full Text] [Related]
11. [Blocking action of berberine on alpha 2 and alpha 1 adrenoceptors in the rat vas deferens and anococcygeus muscle].
Yao WX; Ling BD; Chen B; Han H; Fang DC; Jiang MX
Zhongguo Yao Li Xue Bao; 1986 Nov; 7(6):511-5. PubMed ID: 2886004
[No Abstract] [Full Text] [Related]
12. Vasoconstrictor responses of rat tail artery to sympathetic nerve stimulation contain a component due to activation of postjunctional beta- or alpha 2-adrenoceptors.
Rajanayagam MA; Medgett IC; Rand MJ
Eur J Pharmacol; 1990 Feb; 177(1-2):35-41. PubMed ID: 1971218
[TBL] [Abstract][Full Text] [Related]
13. Vagal and splanchnic neural influences on gastric and duodenal bicarbonate secretions. An experimental study in the cat.
Fändriks L
Acta Physiol Scand Suppl; 1986; 555():1-39. PubMed ID: 2880455
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat.
Dennis T; L'Heureux R; Carter C; Scatton B
J Pharmacol Exp Ther; 1987 May; 241(2):642-9. PubMed ID: 3033221
[TBL] [Abstract][Full Text] [Related]
15. In vivo selectivity of prazosin but not of WB4101 for postsynaptic alpha-1 adrenoceptors.
Massingham R; Dubocovich ML; Shepperson NB; Langer SZ
J Pharmacol Exp Ther; 1981 May; 217(2):467-74. PubMed ID: 6112260
[No Abstract] [Full Text] [Related]
16. Effects of acute and chronic administration of idazoxan on blood pressure and plasma catecholamine concentrations of rats.
Harland D; Brown MJ
J Pharmacol Exp Ther; 1988 Apr; 245(1):265-73. PubMed ID: 3361445
[TBL] [Abstract][Full Text] [Related]
17. Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteries.
Kopia GA; Kopaciewicz LJ; Ruffolo RR
J Pharmacol Exp Ther; 1986 Dec; 239(3):641-7. PubMed ID: 2879028
[TBL] [Abstract][Full Text] [Related]
18. Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia.
Angel I; Niddam R; Langer SZ
J Pharmacol Exp Ther; 1990 Sep; 254(3):877-82. PubMed ID: 1975624
[TBL] [Abstract][Full Text] [Related]
19. (Imidazolinyl-2)-2-benzodioxane 1-4 (idazoxan) and its stereoisomers, new alpha 2-antagonists.
Dabiré H; Mouille P; Schmitt H
J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S127-9. PubMed ID: 2414573
[TBL] [Abstract][Full Text] [Related]
20. Idazoxan: a novel pharmacological tool for the study of alpha 2-adrenoceptors.
Dabiré H
J Pharmacol; 1986; 17(2):113-8. PubMed ID: 2875218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
